HYPERION DEFI, INC. Interest Expense on Debt
HYPERION DEFI, INC. (HYPD) reported Interest Expense on Debt of $380.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseDebt · last filed 2026-03-30
- HYPERION DEFI, INC. interest expense, debt for the quarter ending 2025-12-31 was $84.67K.
- HYPERION DEFI, INC. interest expense, debt for the quarter ending 2025-09-30 was $83.81K.
- HYPERION DEFI, INC. interest expense, debt for the quarter ending 2022-03-31 was $145.24K, a 12518.33% increase year-over-year.
- HYPERION DEFI, INC. interest expense, debt for the quarter ending 2021-09-30 was $143.39K, a 3649.63% increase year-over-year.
- HYPERION DEFI, INC. interest expense, debt for fiscal 2025 was $380.00K.
- HYPERION DEFI, INC. interest expense, debt for fiscal 2020 was $17.04K.
- HYPERION DEFI, INC. interest expense, debt for fiscal 2019 was $0.00.
| Period end | Interest Expense, Debt 3 month | Interest Expense, Debt 6 month | Interest Expense, Debt 9 month | Interest Expense, Debt 12 month |
|---|---|---|---|---|
| 2025-12-31 | $84.67K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $168.48K derived: sum of 2 quarters · filed 2026-03-30 | $380.00K 10-K · filed 2026-03-30 | |
| 2025-09-30 | $83.81K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $295.33K 10-Q · filed 2025-11-14 | ||
| 2025-06-30 | $211.52K 10-Q · filed 2025-08-13 | |||
| 2022-03-31 | $145.24K 10-Q · filed 2023-05-12 | |||
| 2021-09-30 | $143.39K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $147.87K derived: sum of 2 quarters · filed 2021-11-12 | $150.35K 10-Q · filed 2021-11-12 | $156.21K derived: sum of 4 quarters · filed 2021-11-12 |
| 2021-06-30 | $4.48K 10-Q · filed 2021-08-12 | $6.96K 10-Q · filed 2021-08-12 | $12.82K derived: sum of 3 quarters · filed 2021-08-12 | $16.64K derived: sum of 4 quarters · filed 2021-08-12 |
| 2021-03-31 | $1.15K 10-Q · filed 2021-05-14 | $8.34K derived: sum of 2 quarters · filed 2021-05-14 | $12.16K derived: sum of 3 quarters · filed 2021-05-14 | $16.50K derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-12-31 | $7.19K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $11.01K derived: sum of 2 quarters · filed 2021-03-30 | $15.34K derived: sum of 3 quarters · filed 2021-08-12 | $17.04K 10-K · filed 2021-03-30 |
| 2020-09-30 | $3.82K 10-Q · filed 2020-11-12 | $8.16K derived: sum of 2 quarters · filed 2021-08-12 | $9.86K 10-Q · filed 2020-11-12 | $8.16K derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-06-30 | $4.33K 10-Q · filed 2021-08-12 | $6.03K 10-Q · filed 2021-08-12 | $4.33K derived: sum of 3 quarters · filed 2021-08-12 | $4.33K derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $0.00 10-Q · filed 2021-05-14 | $0.00 derived: sum of 2 quarters · filed 2021-05-14 | $0.00 derived: sum of 3 quarters · filed 2021-05-14 | $0.00 derived: sum of 4 quarters · filed 2021-05-14 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $0.00 derived: sum of 2 quarters · filed 2021-03-30 | $0.00 derived: sum of 3 quarters · filed 2021-03-30 | $0.00 10-K · filed 2021-03-30 |
| 2019-09-30 | $0.00 10-Q · filed 2020-11-12 | $0.00 derived: sum of 2 quarters · filed 2020-11-12 | $0.00 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $0.00 10-Q · filed 2020-08-14 | $0.00 10-Q · filed 2020-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |